
AC Immune SA
ACIU
|
NASDAQ
|
2 Sledující
Company Quality
Profitability Score
15/100
Solvency Score
46/100
Dividends
Dividends data currently unavailable.Earnings
8/5/2025
in 58 days
$3M
Revenue est.
-0.18
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Dr. Andrea Pfeifer Ph.D.
CEO
133
Zaměstnanci
Lausanne
Centrála
CH
Země
Key Metrics TTM
Valuation
Market cap.
$166MEnterprise Value
$151MPrice to Earnings
-3.23Price to Sales
5.86Price to Book
1.78Price to Cash Flow
3.66Profitability
Return on Assets
-24.67%Return on Equity
-45.22%Return on Invested Capital
-45.79%Gross Margin
39.44%Operating Margin
-182.62%Net Margin
-184.05%Liquidity
Quick Ratio
1.53Current Ratio
1.53Cash Ratio
0.20Inventory Turnover
0.00Asset Turnover
0.13Total Liabilities
$116MSolvency
Debt to Assets
0.02Debt to Equity
N/AInterest Coverage
-342.3Equity Ratio
0.45Long-term Debt to Cap.
0.00Altman Z-Score
-2.08Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.